Skip to content

iSert Intraocular Lens 251 (yellow), +28.50DRecalls & reported problems

Hoya Medical Singapore Pte. Ltd. · Class 3 · Implant

All models of iSert Intraocular Lens (69)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04547480450469), received between Apr 22, 2022 and Apr 22, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Break1

Patient problems

  • Failure of Implant1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 22, 2022Break; Break

    DAMAGED HAPTIC AFTER IMPLANTATION. A CRACKED OR BROKEN OPTIC (IN THE MIDDLE), A DAMAGED TRAILING HAPTIC WERE REPORTED. IT WAS ALSO REPORTED THAT IT WAS MORE DIFFICULT THAN USUAL (PUSHING OR SCREWING THE IOL THROUGH THE INJECTOR). THE PRODUCT WAS REPLACED WITH ANOTHER LENS IMMEDIATELY DURING SURGERY. PATIENT IMPACT: EXPLANTATION NO PERMANENT OR NEGATIVE IMPACT ON PATIENT HEALTH EXPECTED.

    Patient problems: Failure of Implant

    MAUDE report 14181553 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page